SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-004561
Filing Date
2014-01-28
Accepted
2014-01-28 16:19:30
Documents
1
Period of Report
2014-01-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3772
  Complete submission text file 0001104659-14-004561.txt   5176
Mailing Address C/O TAMIR BIOTECHNOLOGY, INC. 11 DEER PARK DRIVE, SUITE 204 MONMOUTH JUNCTION NJ 08852
Business Address
BRANCACCIO JOHN P (Reporting) CIK: 0001276551 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55020 | Film No.: 14553214

Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
ContraVir Pharmaceuticals, Inc. (Issuer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations